Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 13  •  04:00PM ET
23.58
Dollar change
-0.16
Percentage change
-0.65
%
Feb 12, 8:30 PMDisappointing FY2026 EPS guidance sparked 17.59% intraday plunge despite Q4 earnings beat.
IndexRUT P/E- EPS (ttm)-16.66 Insider Own1.07% Shs Outstand67.93M Perf Week-18.97%
Market Cap1.60B Forward P/E7.99 EPS next Y2.95 Insider Trans7.43% Shs Float67.20M Perf Month-31.33%
Enterprise Value4.24B PEG0.45 EPS next Q0.50 Inst Own120.12% Short Float15.43% Perf Quarter4.38%
Income-1.13B P/S0.59 EPS this Y3.10% Inst Trans3.73% Short Ratio9.82 Perf Half Y-9.13%
Sales2.73B P/B0.79 EPS next Y34.95% ROA-17.77% Short Interest10.37M Perf YTD-17.44%
Book/sh29.99 P/C9.43 EPS next 5Y17.83% ROE-46.15% 52W High43.92 -46.31% Perf Year-43.39%
Cash/sh2.50 P/FCF- EPS past 3/5Y- - ROIC-24.89% 52W Low19.50 20.92% Perf 3Y-72.65%
Dividend Est.- EV/EBITDA8.46 Sales past 3/5Y-5.77% 10.44% Gross Margin39.85% Volatility10.38% 7.57% Perf 5Y-89.66%
Dividend TTM- EV/Sales1.55 EPS Y/Y TTM44.97% Oper. Margin2.16% ATR (14)2.06 Perf 10Y57.30%
Dividend Ex-Date- Quick Ratio0.90 Sales Y/Y TTM-1.73% Profit Margin-41.41% RSI (14)30.36 Recom2.67
Dividend Gr. 3/5Y- - Current Ratio1.50 EPS Q/Q15.68% SMA20-17.07% Beta0.74 Target Price33.71
Payout- Debt/Eq1.46 Sales Q/Q2.17% SMA50-19.81% Rel Volume2.37 Prev Close23.74
Employees6600 LT Debt/Eq1.37 EarningsFeb 11 AMC SMA200-16.61% Avg Volume1.06M Price23.58
IPOFeb 01, 1991 Option/ShortYes / Yes EPS/Sales Surpr.9.08% 3.26% Trades Volume2,504,999 Change-0.65%
Date Action Analyst Rating Change Price Target Change
Oct-07-25Downgrade Citigroup Buy → Neutral $33
May-08-25Upgrade Jefferies Hold → Buy $44
Dec-11-24Upgrade Citigroup Neutral → Buy $44 → $50
Dec-10-24Initiated Jefferies Hold $43
Sep-19-24Resumed UBS Neutral $42 → $50
Sep-05-24Upgrade Craig Hallum Hold → Buy $40 → $57
Mar-04-24Downgrade UBS Neutral → Sell $70 → $42
Feb-14-24Downgrade JP Morgan Neutral → Underweight $66 → $37
Dec-11-23Downgrade Citigroup Buy → Neutral $95 → $72
Dec-12-22Upgrade Citigroup Neutral → Buy $90 → $125
Feb-12-26 09:45AM
09:25AM
08:30AM
12:00AM
Feb-11-26 06:39PM
05:25PM Loading…
05:25PM
04:56PM
04:27PM
04:05PM
Feb-09-26 10:04PM
Feb-04-26 10:00AM
Feb-03-26 07:12AM
Jan-28-26 11:02PM
Jan-27-26 11:04PM
Jan-22-26 07:12AM
07:00AM Loading…
Jan-21-26 07:00AM
Jan-15-26 10:37AM
Dec-18-25 09:17AM
Dec-11-25 10:32PM
Dec-03-25 11:45AM
Nov-25-25 01:00PM
Nov-24-25 07:00AM
Nov-21-25 05:15PM
Nov-20-25 09:00AM
Nov-12-25 12:35AM
Nov-06-25 01:25PM
11:37AM
09:16AM
12:12AM
Nov-05-25 04:54PM
04:52PM Loading…
04:52PM
04:05PM
Nov-03-25 10:04PM
07:00AM
Oct-30-25 08:25AM
Oct-29-25 07:30AM
Oct-23-25 06:45PM
12:44AM
Oct-22-25 07:00AM
Oct-20-25 01:36PM
Oct-16-25 08:30PM
Oct-07-25 11:30AM
Sep-30-25 09:30AM
Sep-26-25 09:53AM
Sep-25-25 09:00AM
Sep-23-25 11:31PM
Sep-22-25 07:00AM
Sep-18-25 11:30AM
Sep-10-25 12:20AM
Aug-28-25 07:30AM
Aug-21-25 04:30PM
09:00AM
Aug-19-25 04:05PM
Aug-18-25 12:02AM
Aug-14-25 11:13AM
Aug-13-25 03:00PM
12:10AM
Aug-12-25 11:59PM
Aug-08-25 09:45AM
Aug-07-25 09:40AM
Aug-06-25 01:02PM
03:36AM
Aug-05-25 05:57PM
05:14PM
04:10PM
Aug-04-25 01:32PM
Aug-03-25 11:12PM
Jul-29-25 05:00PM
Jul-28-25 12:01PM
Jul-24-25 09:00AM
Jul-22-25 04:30PM
Jul-18-25 03:10PM
Jul-17-25 07:00AM
Jul-16-25 09:39AM
Jul-14-25 07:00AM
07:00AM
Jul-09-25 11:38PM
Jul-08-25 07:42AM
Jul-07-25 10:21AM
07:00AM
Jul-04-25 09:45AM
09:40AM
Jun-24-25 10:43AM
Jun-18-25 12:00PM
09:45AM
09:40AM
Jun-16-25 12:01AM
Jun-11-25 06:56AM
12:32AM
Jun-06-25 11:31AM
Jun-03-25 04:10PM
09:50AM
Jun-02-25 09:45AM
May-22-25 04:30PM
May-21-25 09:44AM
May-16-25 09:50AM
May-15-25 09:45AM
May-09-25 12:01PM
12:41AM
May-08-25 12:10PM
QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Strobeck MatthewDirectorFeb 13 '26Buy23.9610,000239,58627,775Feb 13 04:20 PM
Busky Joseph M.Chief Financial OfficerFeb 13 '26Buy23.663,37079,74210,290Feb 13 12:44 PM
Blaser Brian J.President and CEOFeb 13 '26Buy23.5910,540248,66140,073Feb 13 10:43 AM
RHOADS ANN DDirectorDec 10 '25Buy28.2775021,20615,021Dec 10 06:37 PM
Wilkins Joseph D Jr.DirectorNov 26 '25Buy27.9537010,34311,876Dec 01 04:33 PM
WIDDER KENNETH JDirectorNov 25 '25Option Exercise15.747,021110,51141,087Nov 25 04:16 PM
WIDDER KENNETH JDirectorNov 25 '25Sale27.814,026111,96537,061Nov 25 04:16 PM
KENNETH WIDDERDirectorNov 25 '25Proposed Sale27.814,026111,965Nov 25 04:11 PM
Busky Joseph M.Chief Financial OfficerNov 24 '25Buy26.064,770124,3056,920Nov 25 01:21 PM
POLAN MARY LAKE PH DDirectorNov 21 '25Buy22.431,00022,43012,640Nov 24 04:09 PM
Blaser Brian J.President and CEONov 19 '25Buy21.3423,500501,57729,533Nov 20 04:16 PM
BUECHLER KENNETH FDirectorJul 15 '25Option Exercise15.749,215145,044101,921Jul 17 04:09 PM
Last Close
Feb 13  •  04:00PM ET
88.09
Dollar change
+0.87
Percentage change
1.00
%
GMED Globus Medical Inc daily Stock Chart
Index- P/E28.47 EPS (ttm)3.09 Insider Own17.27% Shs Outstand112.18M Perf Week0.32%
Market Cap11.86B Forward P/E21.15 EPS next Y4.17 Insider Trans-0.45% Shs Float111.36M Perf Month-4.73%
Enterprise Value11.59B PEG1.57 EPS next Q1.13 Inst Own85.69% Short Float3.70% Perf Quarter3.99%
Income423.78M P/S4.28 EPS this Y22.72% Inst Trans-0.76% Short Ratio2.77 Perf Half Y46.77%
Sales2.77B P/B2.70 EPS next Y8.11% ROA8.32% Short Interest4.12M Perf YTD0.89%
Book/sh32.68 P/C30.36 EPS next 5Y13.47% ROE10.01% 52W High101.40 -13.12% Perf Year4.71%
Cash/sh2.90 P/FCF20.46 EPS past 3/5Y-19.65% -13.26% ROIC9.41% 52W Low51.79 70.09% Perf 3Y48.22%
Dividend Est.- EV/EBITDA15.99 Sales past 3/5Y38.03% 26.25% Gross Margin61.05% Volatility2.95% 2.67% Perf 5Y30.04%
Dividend TTM- EV/Sales4.18 EPS Y/Y TTM364.73% Oper. Margin16.20% ATR (14)2.60 Perf 10Y289.61%
Dividend Ex-Date- Quick Ratio2.47 Sales Y/Y TTM11.75% Profit Margin15.30% RSI (14)45.24 Recom1.82
Dividend Gr. 3/5Y- - Current Ratio4.13 EPS Q/Q134.07% SMA20-2.38% Beta1.07 Target Price107.00
Payout0.00% Debt/Eq0.03 Sales Q/Q22.91% SMA50-1.73% Rel Volume0.56 Prev Close87.22
Employees5300 LT Debt/Eq0.02 EarningsFeb 24 AMC SMA20027.33% Avg Volume1.49M Price88.09
IPOAug 03, 2012 Option/ShortYes / Yes EPS/Sales Surpr.51.13% 4.68% Trades Volume836,773 Change1.00%
Date Action Analyst Rating Change Price Target Change
Jan-30-26Upgrade Needham Hold → Buy $112
Jan-27-26Initiated TD Cowen Buy $110
Nov-07-25Upgrade Truist Hold → Buy $93
Nov-07-25Upgrade BofA Securities Neutral → Buy $91
Oct-28-25Resumed Stifel Hold $64
May-27-25Downgrade BTIG Research Buy → Neutral
Jan-10-25Upgrade BofA Securities Underperform → Neutral $97
Dec-02-24Upgrade Morgan Stanley Equal-Weight → Overweight $83 → $100
Aug-07-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $78
May-20-24Upgrade Piper Sandler Neutral → Overweight $60 → $80
Today 06:53AM
Feb-13-26 09:39AM
Feb-12-26 04:30PM
10:00AM
Feb-11-26 09:45AM
08:57AM Loading…
Feb-10-26 08:57AM
Feb-09-26 08:02AM
Feb-05-26 10:45AM
09:40AM
08:09AM
Feb-04-26 11:03PM
Feb-03-26 11:40AM
10:23AM
Feb-02-26 04:06PM
Jan-27-26 09:50AM
07:45AM Loading…
07:45AM
Jan-26-26 12:23PM
09:50AM
09:45AM
Jan-21-26 11:37PM
12:10PM
Jan-20-26 08:36AM
Jan-16-26 11:46AM
Jan-12-26 11:32PM
Jan-11-26 11:37PM
Jan-09-26 09:45AM
Jan-08-26 04:39PM
11:43AM
11:23AM
09:50AM
06:31AM Loading…
06:31AM
05:12AM
Jan-07-26 07:11PM
04:27PM
Jan-03-26 08:00AM
Dec-31-25 07:32AM
Dec-23-25 09:45AM
Dec-22-25 03:00PM
Dec-19-25 09:40AM
Dec-18-25 11:12PM
03:11PM
09:08AM
Dec-08-25 10:33PM
Dec-04-25 11:43AM
09:45AM
08:27AM
Dec-03-25 12:45PM
12:43PM
11:40AM
09:40AM
08:14AM
08:08AM
Dec-02-25 09:50AM
08:25AM
07:53AM
Dec-01-25 05:12PM
09:04AM
07:52AM
Nov-26-25 03:27AM
Nov-25-25 02:42PM
08:24AM
07:03AM
Nov-24-25 05:15PM
01:47PM
11:35AM
09:55AM
Nov-20-25 05:46PM
09:16AM
Nov-19-25 01:45PM
Nov-18-25 01:56PM
Nov-17-25 09:33AM
Nov-14-25 12:45PM
10:19AM
09:50AM
08:21AM
Nov-13-25 08:52AM
12:35AM
Nov-11-25 09:45AM
Nov-10-25 11:41PM
Nov-09-25 12:40PM
Nov-07-25 04:21PM
04:14PM
02:17PM
01:11PM
11:08AM
11:04AM
09:26AM
06:36AM
Nov-06-25 07:30PM
06:55PM
05:55PM
05:08PM
04:15PM
Nov-05-25 07:10PM
11:54AM
09:15AM
Nov-04-25 10:12PM
06:20PM
08:39AM
08:39AM
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Huller KellyOfficerFeb 12 '26Proposed Sale87.6010,000876,000Feb 12 12:12 PM
Kline KyleSenior Vice President, CFOJan 08 '26Option Exercise51.873,594186,4213,594Jan 12 05:40 PM
Kline KyleSenior Vice President, CFOJan 08 '26Sale101.103,594363,3530Jan 12 05:40 PM
Norwalk Leslie VDirectorJan 08 '26Sale101.102,000202,20010,419Jan 12 05:36 PM
Kline KyleOfficerJan 08 '26Proposed Sale101.053,594363,167Jan 08 01:52 PM
Norwalk Leslie VDirectorJan 08 '26Proposed Sale101.002,000202,000Jan 08 01:10 PM
Norwalk Leslie VDirectorDec 12 '25Sale88.854,000355,40012,419Dec 16 04:18 PM
Norwalk Leslie VDirectorDec 12 '25Proposed Sale88.754,000355,000Dec 12 04:00 PM
Paul David CExecutive ChairmanDec 08 '25Option Exercise25.5234,375877,25060,417Dec 10 04:37 PM
Kline KyleSenior Vice President, CFODec 01 '25Option Exercise59.8618,5421,109,87618,542Dec 03 08:23 PM
Kline KyleSenior Vice President, CFODec 01 '25Sale90.0018,5421,668,7800Dec 03 08:23 PM
Kline KyleOfficerDec 01 '25Proposed Sale89.9518,5421,667,847Dec 01 03:59 PM
Huller KellySVP, GC, Corporate SecretaryNov 25 '25Option Exercise25.967,500194,7007,500Nov 28 05:31 PM
Huller KellySVP, GC, Corporate SecretaryNov 25 '25Sale90.007,500675,0000Nov 28 05:31 PM
Huller KellyOfficerNov 25 '25Proposed Sale90.007,500675,000Nov 25 11:07 AM
Davidar David DDirectorNov 12 '25Option Exercise25.5225,000638,000541,275Nov 13 05:12 PM
Davidar David DDirectorNov 12 '25Sale86.0025,0002,150,005516,275Nov 13 05:12 PM
ZARRILLI STEPHEN TDirectorNov 11 '25Option Exercise44.1425,0001,103,50025,000Nov 13 05:06 PM
ZARRILLI STEPHEN TDirectorNov 11 '25Sale84.2925,0002,107,2580Nov 13 05:06 PM
Davidar David DDirectorNov 12 '25Proposed Sale85.9525,0002,148,750Nov 12 12:35 PM
ZARRILLI STEPHEN TDirectorNov 11 '25Proposed Sale84.2425,0002,106,000Nov 12 08:45 AM
RHOADS ANN DDirectorNov 10 '25Proposed Sale85.002,000170,000Nov 10 04:55 PM
RHOADS ANN DDirectorNov 07 '25Sale81.008,000648,00017,384Nov 10 04:15 PM
RHOADS ANN DDirectorNov 10 '25Sale85.002,000170,00015,384Nov 10 04:15 PM
RHOADS ANN DDirectorNov 07 '25Proposed Sale80.968,000647,681Nov 07 12:17 PM
RHOADS ANN DDirectorSep 15 '25Sale58.4610,000584,60025,384Sep 16 05:16 PM
RHOADS ANN DDirectorSep 15 '25Proposed Sale58.4010,000584,000Sep 15 03:51 PM
RHOADS ANN DDirectorFeb 28 '25Sale78.687,500590,10035,384Mar 04 04:38 PM
RHOADS ANN DDirectorFeb 28 '25Proposed Sale78.677,500590,000Feb 28 11:05 AM